Supreme Court: Banks Cannot Effectively Blacklist Lawyers by Placing Them on Caution Lists  ||  Madras HC: Advocates Can't Seek Out-of-Turn Case Listing Through Writ Petitions  ||  J&K&L HC: Vehicle Can't Remain in Police Custody During NDPS Trial over Possible Confiscation  ||  J&K&L HC: Prolonged Stagnation in Small Cadres Does Not Grant Right to Promotion  ||  Delhi HC Rejects Bail Plea of Athar Khan in Alleged Delhi Riots Conspiracy  ||  Delhi HC Full Bench: School Employee's Suspension Ends if DOE Approval Isn't Given in 15 Days  ||  Allahabad HC: Mere Note of Failed Conciliation Not Sufficient for Lok Adalat Proceedings  ||  Delhi HC: Govt Created 'Utter Chaos' in OBC Reservation Rules Through Conflicting Notifications  ||  Calcutta HC: Acceptance of Rent After Quit Notice Doesn't Waive Tenancy Termination  ||  Delhi HC Flags EFI Selection Criteria Breach in Asian Games Dressage Team, Declines to Interfere    

Delhi HC Issues Notice in PIL Seeking Selling of Remdesivir by All Pharma Firms in Domestic Market - (04 May 2021)

CIVIL

Delhi High Court has issued notice to the Centre and various pharma majors asking them to respond to a Public Interest Litigation seeking that all drug firms involved in the making Remdesivir be allowed to sell it in the domestic market. The Court has issued the notice to the Health Ministry, Central Drugs Standard Control Organisation, Director General of Foreign Trade, and various pharma companies, like Cipla, Zydus, and Cadila, seeking their stand on the issue.

Tags : DELHI HIGH COURT   SELLING OF REMDESIVIR  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved